PMLiVE55m
J&J’s shares positive results for subcutaneous Tremfya in phase 3 ulcerative colitis trial
Johnson & Johnson (J&J) has shared positive results from a late-stage study evaluating a subcutaneous (SC) version of Tremfya ...
Immunic Presents Key Vidofludimus Calcium Data At The ACTRIMS Forum 2025, Highlighting Its Potential In Multiple Sclerosis
Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April – NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX ) , a ...